Crystalline forms and salt forms of a kinase inhibitor
MYPI2025001620A0Undetermined Publication Date: 2020-06-13EXELIXIS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025001620
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-12-12
- Filing Date
- 2019-12-12
- Publication Date
- 2020-06-13
Abstract
The present invention relates to crystalline forms of the free base of the c-Met inhibitor, Compound 1. The invention also relates to crystalline forms of salts of Compound 1. The invention also relates to pharmaceutical compositions comprising the solid polymorphs of the free base and salts of Compound 1. The invention further relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase.
Need to check novelty before this filing date? Find Prior Art
